Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: A new strategy for studying the immunologic relatedness of HIV-1

被引:101
作者
Nyambi, PN
Gorny, MK
Bastiani, L
van der Groen, G
Williams, C
Zolla-Pazner, S
机构
[1] Vet Affairs Med Ctr, Res Ctr AIDS & HIV Infect, New York, NY 10010 USA
[2] NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA
[3] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium
关键词
D O I
10.1128/JVI.72.11.9384-9391.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To study the antigenic conservation of epitopes of human immunodeficiency virus type 1 (HIV-1) isolates of different clades, the abilities of human anti-HIV-1 gp120 and gp ll monoclonal antibodies (MAbs) to bind to intact HIV-1 virions were determined by a newly developed virus-binding assay. Eighteen human anti-HIV MAbs, which were directed at the V2, V3 loop, CD4-binding domain (CD4bd), C5, or gp41 regions, were used. Nine HIV-1 isolates from clades A, B, D, F, G, and H were used. Microtiter wells were coated with the MAbs, after which virus was added. Bound virus was detected after lysis by testing for p24 antigen with a noncommercial p24 enzyme-linked immunosorbent assay. The anti-V3 MAbs strongly bound the four clade B viruses and viruses from the non-B clades, although binding was weaker and more sporadic with the latter, The degrees of binding by the anti-V3 MAbs to CXCR4- and CCR5-tropic viruses were similar, suggesting that the V3 loops of these two categories of viruses are similarly exposed, The anti-C5 MAbs bound isolates of clades A, B, and D. Only weak and sporadic binding of all the viruses tested with anti-CD4bd, anti-V2, and anti-gp41 MAbs was detected. These results suggest that V3 and C5 structures are shared and well exposed on intact virions of different clades compared to the CD4bd, V2, and gp41 regions.
引用
收藏
页码:9384 / 9391
页数:8
相关论文
共 55 条
[1]   GENERATION OF NEUTRALIZING ANTI-B19 PARVOVIRUS HUMAN MONOCLONAL-ANTIBODIES FROM PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
ARAKELOV, S ;
GORNY, MK ;
WILLIAMS, C ;
RIGGIN, CH ;
BRADY, F ;
COLLETT, MS ;
ZOLLAPAZNER, S .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :580-585
[2]   Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1 [J].
Armstrong, SJ ;
McInerney, TL ;
McLain, L ;
Wahren, B ;
Hinkula, J ;
Levi, M ;
Dimmock, NJ .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2931-2941
[3]   Varying temperature dependence of post attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp120: Identification of a very early fusion-independent event as a neutralization target [J].
Armstrong, SJ ;
Dimmock, NJ .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :1397-1402
[4]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[5]   Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: An approach for HIV type 1 serological subtyping [J].
Barin, F ;
Lahbabi, Y ;
Buzelay, L ;
Lejeune, B ;
BaillouBeaufils, A ;
Denis, F ;
Mathiot, C ;
MBoup, S ;
Vithayasai, V ;
Dietrich, U ;
Goudeau, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (13) :1279-1289
[6]   Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions [J].
Bastiani, L ;
Laal, S ;
Kim, M ;
ZollaPazner, S .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3444-3450
[7]  
Bjorndal A, 1997, J VIROL, V71, P7478
[8]   CARBOHYDRATE DETERMINANT NEUAC-GAL-BETA(1-4) OF N-LINKED GLYCANS MODULATES THE ANTIGENIC ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120 [J].
BOLMSTEDT, A ;
OLOFSSON, S ;
SJOGRENJANSSON, E ;
JEANSSON, S ;
SJOBLOM, I ;
AKERBLOM, L ;
HANSEN, JES ;
HU, SL .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :3099-3105
[9]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013
[10]   ANTIGENIC IMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE QUATERNARY STRUCTURE - OLIGOMER-SPECIFIC AND OLIGOMER-SENSITIVE MONOCLONAL-ANTIBODIES [J].
BRODER, CC ;
EARL, PL ;
LONG, D ;
ABEDON, ST ;
MOSS, B ;
DOMS, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11699-11703